Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$156.08 /

-0.89 (-0.57%)

19:01
03/19/19
03/19
19:01
03/19/19
19:01

Sage says Zulresso approval represents 'game-changing approach' to PPD

Sage Therapeutics announced today the U.S. Food and Drug Administration has approved ZULPRESSO injection for the treatment of postpartum depression. ZULRESSO is the first and only medicine specifically approved to treat PPD, the most common medical complication of childbirth. ZULRESSO is expected to be available in late June following scheduling by the U.S. Drug Enforcement Administration, which is expected to occur within 90 days. "Today's approval of ZULRESSO represents a game-changing approach to treating PPD," said Samantha Meltzer Brody, M.D., M.P.H., Ray M Hayworth Distinguished Professorship of Mood and Anxiety Disorders and director of the Perinatal Psychiatry Program, UNC Center for Women's Mood Disorders and primary investigator of the ZULRESSO clinical trials. "The potential to rapidly reduce symptoms in this critical disorder is an exciting milestone in women's mental health. PPD is recognized to have a significant and long-term impact on women and their families, but with ZULRESSO we may finally have the opportunity to change that." "We are proud to be a part of this important moment in mental health, creating the opportunity for an unprecedented change in the way postpartum depression is thought about and treated moving forward," said Jeff Jonas, M.D., chief executive officer of Sage. "We are grateful for the patients, researchers, healthcare providers, advocates, caregivers and Sage employees who helped secure the approval of the first medicine specifically for postpartum depression. Not only do we believe ZULRESSO will address an important need for women's mental health, the impact of PPD is multi-generational, and we look forward to bringing ZULRESSO to patients in urgent need of a new treatment option. We believe ZULRESSO will be a catalyst in starting a new dialogue emphasizing the importance of women's mental health, and the importance of diagnosing and treating PPD."

  • 19

    Mar

SAGE Sage Therapeutics
$156.08 /

-0.89 (-0.57%)

02/22/19 Guggenheim
Sage Therapeutics initiated with a Buy at Guggenheim
02/19/19 Piper Sandler
Piper sees 'significant unrealized value' in shares of Sage Therapeutics
01/07/19 Piper Sandler
Sage could be up over 50% folllowing 'clear win' in PPD, says Piper Jaffray
12/27/18 Piper Sandler
Sage's 217 PPD data to be 'important' inflection point in Q1, says Piper Jaffray

TODAY'S FREE FLY STORIES

General news
U.S. New home sales beat estimates » 10:45
02/26/20
02/26
10:45
02/26/20
10:45

U.S. New home sales beat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Put buyer in Real Estate ETF possibly closing » 10:40
02/26/20
02/26
10:40
02/26/20
10:40
IYR

DJ US Real Estate Index Fund

$96.61 /

+0.37 (+0.38%)

Put buyer in Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Momenta remains a top pick after Q4 report at Piper Sandler » 10:38
02/26/20
02/26
10:38
02/26/20
10:38
MNTA

Momenta

$31.93 /

+1.14 (+3.70%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fly Intel: What to watch in Square earnings report » 10:35
02/26/20
02/26
10:35
02/26/20
10:35
SQ

Square

$77.93 /

+0.925 (+1.20%)

, UPS

UPS

$94.65 /

+0.75 (+0.80%)

, SHOP

Shopify

$473.00 /

+6.38 (+1.37%)

Square (SQ) is scheduled…

Square (SQ) is scheduled to report results of its fourth fiscal quarter after the market close on February 26, with a conference call scheduled for 5:00 pm EDT. What to watch for: 1. OUTLOOK: During the company's last earnings call, Square said it sees Q4 earnings per share between 19c-21c, with consensus at 25c, and Q4 revenue of $585M-$595M, below the expected $621.24M. The company also narrowed its fiscal year 2019 earnings per share view to 76c-78c from 74c-78c, and its revenue view to $2.24B-$2.25B from $2.25B-$2.28B. 2. REVENUE BEAT POSSIBLE: Last month, Stephens analyst Brett Huff upgraded Square to Overweight from Equal Weight and raised his price target on the shares to $78 from $71, saying he expects the company to beat revenue estimates and meet EBITDA expectations when it reports Q4 results. The analyst also said he sees the company issuing in-line fiscal year 2020 guidance and believes margin expectations have already been reset while the market is underestimating pricing benefits. 3. INSTANT TRANSFERS FEES: In a post to its corporate blog back in January, Square announced that "the rate for instant and same-day transfers from your Square balance to your bank account is changing to 1.5% per transfer. We've recently launched a variety of fast and free transfer options, so we felt the timing was right for this change." 4. COLLABORATION: UPS (UPS) has announced a new collaboration with Square that offers turnkey UPS shipping options integrated into the Square Online Store, "a service that allows small and medium sized sellers to grow their business with a professional e-commerce website and integrated tools." Kevin Warren, UPS's Chief Marketing Officer, said that, "UPS understands that making shipping seamless for small businesses is an essential ingredient to success and to growth. This collaboration gives Square's customers simple and affordable access to UPS's top-tier shipping services within the same familiar platform they're already using." Commenting on the announcement, Keefe Bruyette analyst Steven Kwok told investors that he sees Square's online store customers benefiting from special UPS shipping rates and discounts. Square's online store services, which launched in early 2019, mirrors the business model used by Shopify (SHOP) by helping power online businesses for small merchants with tools such as website building and design, payments, Kwok pointed out, adding that the integration with UPS could enhance Square's positioning to better compete with peers such as Shopify.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Energy Action: WTI crude » 10:35
02/26/20
02/26
10:35
02/26/20
10:35

Energy Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General News
Crude inventories for week of February 21 » 10:30
02/26/20
02/26
10:30
02/26/20
10:30
USO

United States Oil Fund

$10.45 /

+0.04 (+0.38%)

Crude oil inventories…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Treasury Action: Treasuries retain a cautious bid » 10:30
02/26/20
02/26
10:30
02/26/20
10:30

Treasury Action:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Brink's trading resumes  10:27
02/26/20
02/26
10:27
02/26/20
10:27
BCO

Brink's

$80.43 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Inseego call volume above normal and directionally bullish » 10:25
02/26/20
02/26
10:25
02/26/20
10:25
INSG

Inseego

$7.50 /

-0.18 (-2.34%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call » 10:25
02/26/20
02/26
10:25
02/26/20
10:25

Alternative Energy &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 10:17
02/26/20
02/26
10:17
02/26/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NYSE market internals summary » 10:16
02/26/20
02/26
10:16
02/26/20
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Walmart exploring sale of stake in Asda, Bloomberg reports » 10:15
02/26/20
02/26
10:15
02/26/20
10:15
WMT

Walmart

$114.37 /

-0.06 (-0.05%)

Walmart is exploring the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. January new home sales climbed a hefty 7.9% to 764k » 10:15
02/26/20
02/26
10:15
02/26/20
10:15

U.S. January new home…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 2/21 EIA Petroleum Status Report to be released at 10:30  10:15
02/26/20
02/26
10:15
02/26/20
10:15
 
General news
Week of 2/21 EIA Petroleum Status Report to be released at 10:30  10:15
02/26/20
02/26
10:15
02/26/20
10:15
 
Hot Stocks
GrowGeneration acquires Florida-based Healthy Harvest, terms not disclosed » 10:14
02/26/20
02/26
10:14
02/26/20
10:14
GRWG

GrowGeneration

$5.22 /

+ (+0.00%)

GrowGeneration announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Brink's to acquire majority of G4S cash operations for $860M » 10:14
02/26/20
02/26
10:14
02/26/20
10:14
BCO

Brink's

$80.43 /

+ (+0.00%)

The Brink's Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Walmart announces launch of Walmart Fulfillment Services » 10:13
02/26/20
02/26
10:13
02/26/20
10:13
WMT

Walmart

$114.40 /

-0.03 (-0.03%)

Walmart is launching a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Aptorum Group prices $10M registered direct offering » 10:11
02/26/20
02/26
10:11
02/26/20
10:11
APM

Aptorum Group

$6.91 /

-7.525 (-52.15%)

Aptorum Group Limited…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
State Street Investor Confidence Index data reported » 10:10
02/26/20
02/26
10:10
02/26/20
10:10

February State Street…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Walmart exploring sale of stake in Asda, Bloomberg reports  10:10
02/26/20
02/26
10:10
02/26/20
10:10
WMT

Walmart

$114.54 /

+0.11 (+0.10%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: The dolla » 10:10
02/26/20
02/26
10:10
02/26/20
10:10

FX Action: The dollar was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Fly Intel: Top five analyst initiations » 10:07
02/26/20
02/26
10:07
02/26/20
10:07
CSPR

Casper Sleep

$9.65 /

-0.045 (-0.46%)

, VERT

VerticalNet

$0.00 /

+ (+0.00%)

, BR

Broadridge

$114.86 /

+2.385 (+2.12%)

, AVDL

Avadel Pharmaceuticals

$10.51 /

+0.24 (+2.34%)

, DTE

DTE Energy

$128.14 /

+ (+0.00%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Casper Sleep (CSPR) initiated with a Neutral at Wedbush. 2. VerticalNet (VERT) initiated with an Outperform at Cowen. 3. Broadridge (BR) initiated with a Buy at BTIG. 4. Avadel Pharmaceuticals (AVDL) initiated with an Overweight at Piper Sandler. 5. DTE Energy (DTE) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Fly Intel: Top five analyst downgrades » 10:07
02/26/20
02/26
10:07
02/26/20
10:07
NKE

Nike

$93.29 /

+0.42 (+0.45%)

, HUYA

Huya

$19.39 /

+0.08 (+0.41%)

, TOL

Toll Brothers

$39.18 /

-5.095 (-11.51%)

, TM

Toyota

$135.99 /

+1.975 (+1.47%)

, REGN

Regeneron

$450.26 /

+7.92 (+1.79%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Hold from Buy at HSBC with analyst Erwan Rambourg saying while he believes Nike, which he calls the "LVMH of sporting goods," continues putting pressure on competitors with its long-term investments, he sees a "somewhat stretched valuation" and Chinese profit risks limiting the stock's upside in the near-term. 2. Huya (HUYA) downgraded to Neutral from Buy at Goldman Sachs with analyst Piyush Mubayi citing the expected impact of the COVID-19 outbreak. 3. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Raymond James with analyst Buck Horne citing the company's Q1 results that not only missed key expectations on several fronts, but also included guidance for the remainder of FY20 that raises serious questions about internal cost controls and management's financial visibility. 4. Toyota (TM) downgraded to Neutral from Overweight at JPMorgan. 5. Regeneron (REGN) downgraded to Neutral from Outperform at Baird with analyst Brian Skorney saying the analyst appreciates the "tailwind granted by safety concerns" related to Eylea competitor, Novartis' (NVS) Beovu, he notes the shares are up 50% since his August 2019 upgrade. While the fall of Beovu certainly near-term pressure on Eylea market share, this has now been accounted for in the share price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.